References
- 1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3:521-533.
- 2. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008; 43:1-17.10.1007/s00535-007-2111-3
- 3. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98:694-702.10.1016/0016-5085(90)90290-H
- 4. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012; 2012:718617.
- 5. Volarevic V, Milovanovic M, Ljujic B, et al. Galectin-3 Deficiency Prevents Concanavalin A- Induced Hepatitis in Mice. Hepatology 2012; 55:1954-1964.10.1002/hep.25542
- 6. Jiang H-R, Al Rasebi Z, Mensah-Brown E, et al. Galectin- 3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. J Immunol 2009; 182:1167-1173.
- 7. Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, Mitrovic S, Milosavljevic M, Besra G, Trajkovic V, Arsenijevic N, Lukic ML, Volarevic V. Galectin-3 Plays an Important Proinflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages. J Crohns Colitis. 2016; 10: 593-606.
- 8. Radosavljevic G, Jovanovic I, Majstorovic I, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis 2011; 28:451-462.
- 9. Radosavljevic G, Volarevic V, Jovanovic I, et al. The roles of Galectin-3 in autoimmunity and tumor progression. Immunol Res 2012; 52:100-110.
- 10. Arsenijevic A, Milovanovic M, Milovanovic J, Stojanovic B, Zdravkovic N, Leung PS, Liu FT, Gershwin ME, Lukic ML. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Sci Rep. 2016; 6:23348.
- 11. Pejnovic N, Pantic J, Jovanovic I, et al. Galectin-3 Deficiency Accelerates High-Fat Diet Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets. Diabetes 2013; 62:1932-1944.10.2337/db12-0222
- 12. Frol’ova L, Smetana K Jr, Borovska D, et al. Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 2009; 58:503-512.
- 13. Muller S, Schaffer T, Flogerzi B, et al. Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis 2006; 12:588-597.10.1097/01.MIB.0000225341.37226.7c
- 14. Brazowski E, Dotan I, Tulchinsky H, et al. Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA). Pathol Res Pract 2009; 205:551-558.
- 15. Hsu DK, Yang RY, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000; 156:1073-1083.
- 16. Murthy S, Cooper H, Shim H, et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine. Dig Dis Sci 1993; 38:1722-1734. 10.1007/BF01303184
- 17. Whittem CG, Williams AD, Williams CS. Murine Colitis Modeling using Dextran Sulfate Sodium. J Vis Exp 2010; 35:1652.
- 18. Obermeier F, Kojouharoff G, Hans W, et al. Interferon- gamma (IFNgamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116:238-245.
- 19. Hans W, Scholmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000; 12:267-273.10.1097/00042737-200012030-00002
- 20. Hall GS, Woods GL. Medical bacteriology. In: McPherson RA, Pincus MR, eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. Philadelphia, PA: Elsevier; 2017: chap 58.
- 21. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993; 75:253-261.10.1016/0092-8674(93)80067-O
- 22. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75:263-274.
- 23. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66:5224-5231.
- 24. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121:1320-1328.
- 25. Bodger K, Halfvarson J, Dodson AR, et al. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 2006; 55:973- 977.10.1136/gut.2005.086413
- 26. Hsu DK, Chernyavsky AI, Chen HY, et al. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol 2009; 129:573-583.
- 27. Liu FT, Hsu DK. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect 2007; 20:455-460.10.1358/dnp.2007.20.7.1149628
- 28. Simovic Markovic B, Nikolic A, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V. Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem Cells Int. 2016; 2016:2640746.
- 29. Bodger K, Halfvarson J, Dodson AR, et al. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 2006; 55:973- 977.10.1136/gut.2005.086413
- 30. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56:669-675.10.1136/gut.2006.099796
- 31. Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol. 1998; 51:657-661.10.1136/jcp.51.9.657
- 32. Araki Y, Mukaisho K, Sugihara H, Fujiyama Y, Hattori T. Proteus mirabilis sp. intestinal microflora grow in a dextran sulfate sodium-rich environment. Int J Mol Med. 2010; 25:203-208.
- 33. Videla S, Vilaseca J, Guarner F, Salas A, Treserra F, Crespo E, Antolin M, Malagelada JR. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut. 1994; 35:1090-1097.10.1136/gut.35.8.1090
- 34. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978; 74:521-526.